Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biocell Center is a specialized biotechnology company and the first in the world to offer the cryopreservation of stem cells harvested from amniotic fluid and chorionic villi. The company provides clinical-grade banking services for prenatal stem cells, which are recognized for their high pluripotency and potential in future regenerative medicine applications. Operating with facilities in both Italy and the United States, Biocell Center collaborates with medical institutions to integrate cell collection into routine prenatal diagnostic procedures. Their business model combines commercial biobanking services with active research into the therapeutic use of fetal stem cells for treating various degenerative diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biocell Center.